Breaking News
  • February 5Purchase IHS Improv tickets! Second performance is Feb. 9 at 7 p.m. in the Little Theatre!
  • February 5Congratulations Nathan Choy and Franklyn Xue for qualifying for the American Invitational Mathematics Examination!
  • November 16Congratulations to “Murder on the Nile” for ranking first place in every category in the Seattle Repertory Theatre’s adjudication program!
  • November 16Congratulations to all our National Merit semi-finalists!
The student news site of Inglemoor High School

Nordic News

The student news site of Inglemoor High School

Nordic News

The student news site of Inglemoor High School

Nordic News

Complications of cosmetic consumerism

Merck’s new anti-COVID pill

Merck%E2%80%99s+new+anti-COVID+pill

On Oct. 11, drug manufacturer Merck announced that they had developed an anti-COVID pill that, if approved by the Food and Drug Administration, would be the only approved COVID-19 treatment that does not require an IV or injection. The pill is different from vaccines in that it would be a treatment rather than a prevention, but it would nevertheless play a key role in preventing the spread of and reducing deaths from COVID.

If the pills are approved, the US government will buy enough pills for 1.7 million people. The current price per treatment for the taxpayer is $700, which is more expensive than many pills used to cure other viruses; however, this is only a tentative price that was set before Merck had any data to base their prices on.

While Americans await potential approval for the pill by the FDA on Nov. 30, the United Kingdom has already approved the pill for use for those with COVID and at least one risk factor. As much of Europe recedes back into lockdowns, many other Western countries, such as Canada, are also seeking approval for the drug. The pill has also been licensed to be sold by generic drugmakers in low-income countries.

 

Leave a Comment
More to Discover
About the Contributor
Weiju Wang, Co-Copy Editor
Junior Weiju Wang is heading into his third year in Nordic and second year as a copy editor. He’s excited to work with everyone on staff and continue to contribute to the publication. Outside of Nordic, he participates in the school’s robotics team and a variety of hobbies, including language learning, coding, piano, and calligraphy.

Comments (0)

Please leave your name and email when commenting. Harmful or spam comments will be removed. Visit the comments policy tab for more info.
All Nordic News Picks Reader Picks Sort: Newest

Your email address will not be published. Required fields are marked *

Activate Search
Merck’s new anti-COVID pill